To evaluate the involvement of Rab11-FIP2 in tumor angiogenesis of CRC clinically, we used immunohistochemical staining for CD34 in 28 human CRC tissue samples and calculated the number of CD34-positive microvessels in the tumor area. This evidence concerns the gene OPTN and neoplasm.